|
Serum Ferritin and Prognosis of DKA
RECRUITINGSponsored by Sohag University
Actively Recruiting
SponsorSohag University
Started2025-01-01
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06748365
Summary
the aim of this study is to: evaluate the association between serum ferritin levels and the clinical presentation and short-term prognosis of patients with DKA. Specifically, the correlation between its level and the severity of DKA at presentation and determine its prognostic value in predicting short-term outcomes.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: \- All patients with DKA : 1. Adult Aged 18 years old or older . 2. Type 1 DM , type 2 DM 3. Diagnosis of DKA based on the American Diabetes Association criteria: blood glucose \>250 mg/dL, arterial pH \<7.3, serum bicarbonate \<18 mEq/L, Exclusion Criteria: 1. Patients age less than 18 years old 2. Iron deficiency anemia and iron overload 3. Chronic Inflammatory Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease 4. Acute and chronic infections, including bacterial, viral, and fungal infections 5. Pt presented with other acute complication (MI,stroke) 6. CKD patients 7. Patients with chronic liver diseases 8. Patients with malignancy 9. Pregnant women.
Conditions2
DiabetesDiabetic Ketoacidosis
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSohag University
Started2025-01-01
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06748365